Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sacchi

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
European Journal of Haematology|July 1, 1996
In vivo biological response following low-dose interleukin-2 in complete remission B-cell non-Hodgkin's lymphoma patients. Italian Lymphoma Study Group (GISL)A Vecchi, L Cavanna, P Avanzini, et al.
Leukemia|October 27, 1997
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, S O'Brien, et al.
Leukemia|May 3, 2002
Distinct genomic events in the myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B-chronic lymphocytic leukemiaB Crescenzi, S Sacchi, R Marasca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2009
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending storyA Bari, L Marcheselli, S Sacchi, et al.
Cancer|December 14, 1999
Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patientsS Sacchi, H M Kantarjian, S O'Brien, et al.
Haematologica|December 1, 1979
[Evaluation of platelet kinetics in chronic renal failure (conservative and regular dialysis treatment) (author's transl)]E Lusvarghi, G Curci, S Sacchi, et al.
Leukemia & Lymphoma|December 28, 1999
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemiaS Sacchi, H M Kantarjian, E J Freireich, et al.
Haematologica|January 1, 1997
All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi)S Sacchi, D Russo, G Avvisati, et al.
Leukemia|April 7, 1998
Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. Italian Cooperative Group on ETS Sacchi, L Gugliotta, F Papineschi, et al.
Haematologica|May 18, 1999
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL)G Longo, C Fiorani, S Sacchi, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Haematology|July 1, 1996
In vivo biological response following low-dose interleukin-2 in complete remission B-cell non-Hodgkin's lymphoma patients. Italian Lymphoma Study Group (GISL)A Vecchi, L Cavanna, P Avanzini, et al.
Leukemia|October 27, 1997
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, S O'Brien, et al.
Leukemia|May 3, 2002
Distinct genomic events in the myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B-chronic lymphocytic leukemiaB Crescenzi, S Sacchi, R Marasca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2009
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending storyA Bari, L Marcheselli, S Sacchi, et al.
Cancer|December 14, 1999
Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patientsS Sacchi, H M Kantarjian, S O'Brien, et al.
Haematologica|December 1, 1979
[Evaluation of platelet kinetics in chronic renal failure (conservative and regular dialysis treatment) (author's transl)]E Lusvarghi, G Curci, S Sacchi, et al.
Leukemia & Lymphoma|December 28, 1999
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemiaS Sacchi, H M Kantarjian, E J Freireich, et al.
Haematologica|January 1, 1997
All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi)S Sacchi, D Russo, G Avvisati, et al.
Leukemia|April 7, 1998
Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. Italian Cooperative Group on ETS Sacchi, L Gugliotta, F Papineschi, et al.
Haematologica|May 18, 1999
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL)G Longo, C Fiorani, S Sacchi, et al.
Pageof 11